Oxford
Branch
Branch
LAB282 is a new funding partnership in Oxford, which has just awarded its first grants. We interviewed Dr Thomas Hanke, Expert in Residence at LAB282 and Head of Academic Partnerships at Evotec. Read on to find out what is so unique about LAB282, what it can offer and, most importantly, how to get them toaaa
Read moreOxford University and Evotec’s drug discovery partnership launched last November to accelerate drugs to market begins making awards. Hamburg, Germany, 21 February 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) is pleased to announce that LAB282, the £13m drug discovery partnership with Oxford University, has made its first wave of awards, backing projectsaaa
Read more